Change - Announcement of Cessation::Resignation of Executive Director and Group Chief Executive Officer

Issuer & Securities

Issuer/ Manager
AOXIN Q & M DENTAL GRP LIMITED
Securities
AOXIN Q & M DENTAL GRP LIMITED - SG1DF9000000 - 1D4
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
22-Jul-2025 14:55:43
Status
New
Announcement Sub Title
Resignation of Executive Director and Group Chief Executive Officer
Announcement Reference
SG250722OTHR89EE
Submitted By (Co./ Ind. Name)
Mr Chua Ser Miang
Designation
Non-Executive Chairman and Independent Director
Description (Please provide a detailed description of the event in the box below)
Please refer to attached.

Additional Details

Name Of Person
Shao Yongxin
Age
63
Is effective date of cessation known?
Yes
If yes, please provide the date
21/07/2025
Detailed Reason (s) for cessation
There exist differences in views and opinions with major shareholder in relation to strategic direction of the dental business in Liaoning province, the People's Republic of China ("PRC"). As such, Dr Shao Yongxin ("Dr Shao") decided to step down as Executive Director and Group Chief Executive Officer.

After having interviewed Dr Shao and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte Ltd., is satisfied that, save as disclosed in this announcement, there are no other material reasons for the cessation of Dr Shao as Executive Director and Group Chief Executive Officer.

Having considered the size and nature of the PRC dental business, the role and scope of the Chief Executive Officer will be subsumed by the General Manager Dr Bai Yi and Deputy General Manager Mr Huang Zhenxing, both of whom will report directly to the Board. Dr Shao will work closely with both Dr Bai Yi and Mr Huang Zhenxing for the handover of duties.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Yes
If Yes, Please provide full details
The Audit Committee ("AC") received a whistle-blowing report against Dr Shao on 21 July 2025 and has commenced investigation into the matter. The Board, on the recommendation of the AC, will update shareholders as soon as investigation is completed.
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Yes
If Yes, Please provide full details
Please refer to the above.
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
24/02/2017
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Group Chief Executive Officer
Role and responsibilities
Responsible for the overall strategic, management and business development of the Group
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
21,428,229 shares
Past (for the last 5 years)
Nil
Present
- Dean of Jinzhou Medical University Shenyang College of Dentistry
- Q &M Dental (Shenyang) Pte. Ltd.
- Shanghai Q&M Investment Management & Consulting Co., Ltd.
- Shenyang Xinao Hospital Management Co., Ltd.
- Shenyang Quanxin Medical Equipment Leasing Co., Ltd
- Health Field Enterprises Limited
- Action Health Enterprises Limited